Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: A comprehensive review

被引：232
作者：
Angarita G.A. [1 ]
Emadi N. [1 ]
Hodges S. [1 ]
Morgan P.T. [1 ]
机构：
[1] Yale University Department of Psychiatry, Connecticut Mental Health Center, 34 Park Street, New Haven, 06519, CT
来源：
Addiction Science & Clinical Practice | / 11卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Alcohol; Cannabis; Cocaine; Insomnia; Opiates; Sleep;
D O I：
10.1186/s13722-016-0056-7
中图分类号：
学科分类号：
摘要：
Sleep abnormalities are associated with acute and chronic use of addictive substances. Although sleep complaints associated with use and abstinence from addictive substances are widely recognized, familiarity with the underlying sleep abnormalities is often lacking, despite evidence that these sleep abnormalities may be recalcitrant and impede good outcomes. Substantial research has now characterized the abnormalities associated with acute and chronic use of alcohol, cannabis, cocaine, and opiates. This review summarizes this research and discusses the clinical implications of sleep abnormalities in the treatment of substance use disorders. © 2016 Angarita et al.
引用
收藏
相关论文
共 178 条
  • [91] Halikas J.A., Weller R.A., Morse C.L., Hoffmann R.G., A longitudinal study of marijuana effects, Int J Addict, 20, 5, pp. 701-711, (1985)
  • [92] Haney M., Cooper Z.D., Bedi G., Vosburg S.K., Comer S.D., Foltin R.W., Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse, Neuropsychopharmacology, 38, 8, pp. 1557-1565, (2013)
  • [93] Haney M., Hart C.L., Vosburg S.K., Comer S.D., Reed S.C., Cooper Z.D., Foltin R.W., Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse, Psychopharmacology, 211, 2, pp. 233-244, (2010)
  • [94] Haney M., Hart C.L., Vosburg S.K., Comer S.D., Reed S.C., Foltin R.W., Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse, Psychopharmacology, 197, 1, pp. 157-168, (2008)
  • [95] Haney M., Hart C.L., Vosburg S.K., Nasser J., Bennett A., Zubaran C., Foltin R.W., Marijuana withdrawal in humans: Effects of oral THC or divalproex, Neuropsychopharmacology, 29, 1, pp. 158-170, (2004)
  • [96] Haney M., Hart C.L., Ward A.S., Foltin R.W., Nefazodone decreases anxiety during marijuana withdrawal in humans, Psychopharmacology, 165, 2, pp. 157-165, (2003)
  • [97] Haney M., Ward A.S., Comer S.D., Foltin R.W., Fischman M.W., Abstinence symptoms following oral THC administration to humans, Psychopharmacology, 141, 4, pp. 385-394, (1999)
  • [98] Haney M., Ward A.S., Comer S.D., Foltin R.W., Fischman M.W., Abstinence symptoms following smoked marijuana in humans, Psychopharmacology, 141, 4, pp. 395-404, (1999)
  • [99] Haney M., Ward A.S., Comer S.D., Hart C.L., Foltin R.W., Fischman M.W., Bupropion SR worsens mood during marijuana withdrawal in humans, Psychopharmacology, 155, 2, pp. 171-179, (2001)
  • [100] Hartwell E.E., Pfeifer J.G., McCauley J.L., Moran-Santa Maria M., Back S.E., Sleep disturbances and pain among individuals with prescription opioid dependence, Addict Behav, 39, 10, pp. 1537-1542, (2014)
567891011121314